Literature DB >> 11074264

Crosstalk between nervous and immune systems through the animal kingdom: focus on opioids.

M Salzet1, D Vieau, R Day.   

Abstract

During the course of evolution invertebrates and vertebrates have maintained common signaling molecules, such as neuropeptides. For example, complete hormonal-enzymatic systems for the biosynthesis of opioid peptides have been found in both the CNS and immune systems of these animals. These signaling molecules have been found in the blood circulation and act as immunomodulators. In vertebrates, release of the signaling molecules occurs during stress (cognitive or pathogens), which triggers the hypothalamo-hypophysial-adrenal axis. Similarly, these neuropeptides are used as messengers to initiate and stimulate the innate immune response in invertebrates. Thus, the crosstalk between nervous and immune systems has an ancient evolutionary origin and the messengers used have been conserved during the course of evolution reflecting their vital importance.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11074264     DOI: 10.1016/s0166-2236(00)01642-8

Source DB:  PubMed          Journal:  Trends Neurosci        ISSN: 0166-2236            Impact factor:   13.837


  14 in total

1.  Striatal proenkephalin gene induction: coordinated regulation by cyclic AMP and calcium pathways.

Authors:  Christine Konradi; Wendy Macías; Joshua T Dudman; Richard R Carlson
Journal:  Brain Res Mol Brain Res       Date:  2003-07-23

2.  The effects of rotation stress on measures of immunity. The role of opiate receptors.

Authors:  S V Gein; T A Simonenko; S P Tendryakova
Journal:  Neurosci Behav Physiol       Date:  2004-11

3.  The cellular response in neuroinflammation: The role of leukocytes, microglia and astrocytes in neuronal death and survival.

Authors:  Monica J Carson; J Cameron Thrash; Barbara Walter
Journal:  Clin Neurosci Res       Date:  2006-12

4.  Disruption of proprotein convertase 1/3 (PC1/3) expression in mice causes innate immune defects and uncontrolled cytokine secretion.

Authors:  Sarah Refaie; Sandra Gagnon; Hugo Gagnon; Roxane Desjardins; François D'Anjou; Pedro D'Orléans-Juste; Xiaorong Zhu; Donald F Steiner; Nabil G Seidah; Claude Lazure; Michel Salzet; Robert Day
Journal:  J Biol Chem       Date:  2012-03-06       Impact factor: 5.157

5.  Non-breeding feather concentrations of testosterone, corticosterone and cortisol are associated with subsequent survival in wild house sparrows.

Authors:  Lee Koren; Shinichi Nakagawa; Terry Burke; Kiran K Soma; Katherine E Wynne-Edwards; Eli Geffen
Journal:  Proc Biol Sci       Date:  2011-11-16       Impact factor: 5.349

6.  Modulation of neuronal CXCR4 by the micro-opioid agonist DAMGO.

Authors:  Jeegar P Patel; Rajarshi Sengupta; Giuseppe Bardi; Muhammad Z Khan; Anna Mullen-Przeworski; Olimpia Meucci
Journal:  J Neurovirol       Date:  2006-12       Impact factor: 2.643

Review 7.  Critical neurological features of COVID-19: Role of imaging methods and biosensors for effective diagnosis.

Authors:  Vishakha Singh; Prince Allawadhi; Amit Khurana; Anil Kumar Banothu; Kala Kumar Bharani
Journal:  Sens Int       Date:  2021-05-13

8.  Molecular Consequences of Proprotein Convertase 1/3 (PC1/3) Inhibition in Macrophages for Application to Cancer Immunotherapy: A Proteomic Study.

Authors:  Marie Duhamel; Franck Rodet; Nadira Delhem; Fabien Vanden Abeele; Firas Kobeissy; Serge Nataf; Laurent Pays; Roxanne Desjardins; Hugo Gagnon; Maxence Wisztorski; Isabelle Fournier; Robert Day; Michel Salzet
Journal:  Mol Cell Proteomics       Date:  2015-09-01       Impact factor: 5.911

Review 9.  Nuclear factor kappaB signaling in opioid functions and receptor gene expression.

Authors:  Yulong L Chen; Ping-Yee Law; Horace H Loh
Journal:  J Neuroimmune Pharmacol       Date:  2006-07-08       Impact factor: 4.147

10.  Close apposition of dynorphin-positive nerve fibres to lymphocytes in the liver suggests opioidergic neuroimmunomodulation.

Authors:  Matthias J T Kaiser; Gisa Tiegs; Winfried L Neuhuber
Journal:  Histochem Cell Biol       Date:  2003-08-05       Impact factor: 4.304

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.